Chongqing: Strengthening listing guidance and cultivation to promote the listing of biopharmaceutical companies on domestic and foreign capital markets

The General Office of the Chongqing Municipal People's Government has issued the "Several Measures to Support the High-Quality Development of Innovative Drugs in the Full Chain in Chongqing", proposing to increase financial support. It seeks support from national new types of policy-based financial instruments, encourages financial institutions to support enterprises in developing innovative drugs through medium and long-term credit, intellectual property pledge, and bank-leasing cooperation. It also supports enterprises in technology transformation through bank loan interest subsidies, financing lease interest subsidies, and guarantee subsidies. The Chongqing Industrial Investment Mother Fund and other funds play a role in patient capital, guiding and encouraging more social capital to increase investment in innovative drugs. Explore the establishment of special funds in the "Enterprise + State-Owned Capital + Social Capital" model to support large enterprises in forward-looking layout of technology systems and product pipelines. Improve the financing and investment service mechanism for small and medium-sized enterprises. Establish a list of companies for graded bond issuance to support biopharmaceutical companies in bond financing. Strengthen guidance and training for listing, and promote biopharmaceutical companies to go public on domestic and foreign capital markets.